Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Genetic differences affect COVID-19 severity and treatment development.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Immune cells affect hair growth and could lead to new hair loss treatments.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Blocking the NOTCH pathway can prevent fibrosis in systemic sclerosis.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

γδ T cells adapt uniquely to different tissues in mice.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Alopecia areata involves immune response and gene changes affecting hair loss.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.